BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 11514374)

  • 21. Implantable dual-chamber defibrillator for the selective treatment of spontaneous atrial and ventricular arrhythmias: arrhythmia incidence and device performance.
    Schuchert A; Boriani G; Wollmann C; Biffi M; Kühl M; Sperzel J; Stiller S; Gasparini G; Böcker D
    J Interv Card Electrophysiol; 2005 Mar; 12(2):149-56. PubMed ID: 15744468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing.
    Kühlkamp V; Dörnberger V; Mewis C; Suchalla R; Bosch RF; Seipel L
    J Cardiovasc Electrophysiol; 1999 Jul; 10(7):905-15. PubMed ID: 10413370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias.
    Ricci R; Pignalberi C; Disertori M; Capucci A; Padeletti L; Botto G; Toscano S; Miraglia F; Grammatico A; Santini M
    Eur Heart J; 2002 Sep; 23(18):1471-9. PubMed ID: 12208228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation.
    Prakash A; Saksena S; Hill M; Krol RB; Munsif AN; Giorgberidze I; Mathew P; Mehra R
    J Am Coll Cardiol; 1997 Apr; 29(5):1007-14. PubMed ID: 9120152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients.
    Friedman PA; Dijkman B; Warman EN; Xia HA; Mehra R; Stanton MS; Hammill SC
    Circulation; 2001 Aug; 104(9):1023-8. PubMed ID: 11524396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
    Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incremental programming of atrial anti-tachycardia pacing therapies in bradycardia-indicated patients: effects on therapy efficacy and atrial tachyarrhythmia burden.
    Hügl B; Israel CW; Unterberg C; Lawo T; Geller JC; Kennis IM; Euler DE; Koehler JL; Hettrick DA;
    Europace; 2003 Oct; 5(4):403-9. PubMed ID: 14753639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial Rate-Responsive Pacing and Incidence of Sustained Atrial Arrhythmias in Patients with Implantable Cardioverter Defibrillators.
    Fontenla A; Salguero R; Martinez-Ferrer JB; Rodriguez A; Alzueta J; Garcia E; Basterra N; Romero R; Concha JF; Viñolas X; Villacastin J; Lopez-Gil M; Arribas F
    Pacing Clin Electrophysiol; 2016 Jun; 39(6):548-56. PubMed ID: 27001125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of atrial prevention and termination therapies on atrial tachyarrhythmia burden in patients receiving a dual-chamber defibrillator for ventricular arrhythmias.
    Friedman PA; Ip JH; Jazayeri M; Lobban JH; Olshansky B; Zhou D; Knowles T; Euler DE;
    J Interv Card Electrophysiol; 2004 Apr; 10(2):103-10. PubMed ID: 15014210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of high frequency atrial pacing for the termination of acute atrial fibrillation and atypical atrial flutter.
    Shlevkov N; Yang A; Schrickel JW; Schwab JO; Bielik H; Lickfett L; Bitzen A; Nickenig G; Lüderitz B; Lewalter T
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):322-32. PubMed ID: 17367351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: is there any evidence of therapeutic breakthrough?
    Savelieva I; Camm AJ
    J Interv Card Electrophysiol; 2003 Apr; 8(2):103-15. PubMed ID: 12766501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients?
    Stein KM; Euler DE; Mehra R; Seidl K; Slotwiner DJ; Mittal S; Markowitz SM; Lerman BB;
    J Am Coll Cardiol; 2002 Jul; 40(2):335-40. PubMed ID: 12106941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm.
    Pürerfellner H; Ruiter JH; Widdershoven JW; Van Gelder IC; Urban L; Kirchhof CJ; Havlicek A; Kornet L;
    Heart Rhythm; 2006 Oct; 3(10):1164-71. PubMed ID: 17018345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy.
    Israel CW; Hügl B; Unterberg C; Lawo T; Kennis I; Hettrick D; Hohnloser SH;
    J Cardiovasc Electrophysiol; 2001 Oct; 12(10):1121-8. PubMed ID: 11699520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between pacing and arrhythmia detection algorithms in the dual chamber implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Interv Card Electrophysiol; 2001 Sep; 5(3):299-308. PubMed ID: 11500585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrimination of sinus rhythm, atrial flutter, and atrial fibrillation using bipolar endocardial signals.
    Jung J; Hohenberg G; Heisel A; Strauss D; Schieffer H; Fries R
    J Cardiovasc Electrophysiol; 1998 Jul; 9(7):689-95. PubMed ID: 9684716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical impact of surface electrocardiography of cardiac arrhythmias in pacemaker-ICD patients.
    Santini M; Aquilani S; Ricci RP
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():60-3. PubMed ID: 17584683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual chamber arrhythmia detection in the implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Cardiovasc Electrophysiol; 2000 Oct; 11(10):1105-15. PubMed ID: 11059974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.